POD408 Advanced Pharmacology and Prescribing (8)

This subject builds on the student's knowledge of pharmacology, to develop an understanding of the issues associated with the prescription, administration and dispensing of medicines. Students will study the clinical use of a range of S2, S3 and S4 medicines of relevance to podiatric practice. Medico-legal and ethical implications of prescribing will be addressed and students will consider their professional responsibilities as a potential podiatrist prescriber. Areas of study are informed by the prescribing competencies framework and will comprise: understanding the person and their clinical needs; understanding treatment options and how they support the person's clinical needs; working in partnership with the person to develop and implement a treatment plan; communicating the treatment plan clearly to other health professionals; monitoring and reviewing the person's response to treatment. This subject will provide students with a firm foundation from which to apply for endorsement of scheduled medicines and to work towards becoming competent prescribers.


Session 1 (30)
On Campus
Albury-Wodonga Campus

Continuing students should consult the SAL for current offering details: POD408. Where differences exist between the Handbook and the SAL, the SAL should be taken as containing the correct subject offering details.

Subject Information

Grading System



One session


School of Community Health

Enrolment Restrictions

Bachelor of Podiatric Medicine; Bachelor of Podiatric Medicine (Honours)


BMS263 and BMS236

Learning Outcomes

Upon successful completion of this subject, students should:
  • be able to synthesise a podiatry client medical and social history, their own observations and diagnostic testing to appropriately prescribe the required scheduled medicines (S2, S3 & S4) with attention to ethical, social and financial considerations
  • be able to write a prescription that is for the correct schedule medicine with the appropriate dosage
  • be able to apply their knowledge of pharmacodynamics and pharmacokinetics in the context of responsible prescribing for podiatric practice
  • subsequent to prescribing a scheduled medicine, be able to develop a client management plan that monitors, assesses and evaluates the efficacy of the intervention with particular reference to adverse reactions
  • be able to formulate appropriate podiatric prescriptions within the relevant medico-legal frameworks, both state and national


This subject will cover the following topics:
  • Evaluation of ethical and medico-legal implications and professional responsibility of prescribing medicines, including prescription writing
  • Evaluation of the clinical needs of a broad range of clients with lower limb pathology in order to negotiate therapeutic goals
  • Evaluation of pharmacological and non-pharmacological treatment options for a client with lower limb pathology
  • Evaluation of a client's health status to identify possible risks and contraindications for medicines relevant to podiatry practice
  • Dosage of medicines for a range of clients, considering personal issues such as age, gender, weight and size
  • Monitoring and review processes to assess a client's response to treatment
  • Wider community issues in prescribing medicines e.g. cost of medicines; use of generic medicines; antibiotic prescribing
  • Evaluation of the role of interprofessional collaboration in treatment planning, prescription of medicines and client review
  • Evaluation of the potential for bias in prescribing decisions e.g. marketing influences, personal values and beliefs, possible financial gain

Indicative Assessment

The following table summarises the assessment tasks for the online offering of POD408 in Session 1 2020. Please note this is a guide only. Assessment tasks are regularly updated and can also differ to suit the mode of study (online or on campus).

Item Number
Value %
On-line tests of pharmacy content
Case 1: pain management and paediatrics
Case 2: antifungal medications
Case 3: antibiotics and diabetes

The information contained in the CSU Handbook was accurate at the date of publication: May 2021. The University reserves the right to vary the information at any time without notice.